News

Citi Maintains Neutral Rating and Price Target on ADC

Citi Maintains Neutral Rating and Price Target on ADC

Citi Maintains Neutral Rating on Agree Realty Corporation

Recently, Citi has reaffirmed its Neutral rating on Agree Realty Corporation (NYSE: ADC), keeping a steady price target of $77.00. This rating signifies a cautious stance on the stock, reflecting the firm's adjusted assessment of the company's financials.

Financial Adjustments and Impact on FFO

The adjustment made by Citi to the financial model accounts for the actual weighted-average share count reported for the third quarter of 2024. As a result of these changes, they slightly revised their forecast for core Funds From Operations (FFO) and Adjusted Funds From Operations (AFFO) for the fiscal years 2024 and 2025. Specifically, the revised estimates now indicate that core FFO for fiscal year 2024 is projected to be $4.08, down from the prior estimate of $4.10. Similarly, the AFFO estimate has been reduced marginally to $4.12, compared to the earlier figure of $4.13.

Operational Highlights and Financial Results

In addition to these revisions, Agree Realty Corporation has recently reported robust financial outcomes for the second quarter of 2024. This period showcased increased acquisition activity, and the company raised its annual AFFO per share forecast. Furthermore, they took proactive measures by expanding their revolving credit agreement to $1.25 billion, which significantly enhances their financial flexibility. Alongside this, Agree Realty's operating partnership, Agree Limited Partnership, successfully priced a public offering of $450 million in senior unsecured notes due in 2034, which will reinforce the company's financial positioning.

Market Reactions and Analyst Ratings

In response to Agree Realty's recent performance, analysts from Stifel and RBC Capital Markets have positively reacted to the news, raising their price targets for the shares while continuing to hold favorable ratings. Conversely, UBS has initiated coverage of Agree Realty with a Neutral rating, citing concerns over limited growth prospects going forward.

Weighted-Average Share Count and Future Projections

Agree Realty has also provided updates on its weighted-average number of common shares outstanding, relevant for the calculation of earnings per share for the third quarter and the initial nine months of 2024. This accounting includes the impact of dilutive securities, such as share-based compensation and potential shares issued under at-the-market (ATM) forward equity offerings.

Insights from Recent Data

Recent insights related to Agree Realty Corporation (NYSE: ADC) reveal pertinent details for investors. The company's current market capitalization is approximately $7.54 billion, accompanied by a P/E ratio of 41.62. This valuation suggests that the stock is trading at a premium relative to its earnings, which may warrant careful consideration. According to insights, ADC has been recognized for its strong revenue growth, recording $583.01 million over the last twelve months as of Q2 2024, representing a growth rate of 20.68%. This impressive financial performance aligns with a notable total return of 36.81% over the past six months.

Dividend History and Income Potential

Ahighlight of Agree Realty's financial profile is its consistent dividend payment history, having maintained dividends for 31 consecutive years and raised them for 11 consecutive years, showcasing the company’s commitment to delivering shareholder value. Currently, the dividend yield stands at 3.99%, which may attract investors looking for income-generating opportunities, particularly in light of Citi's Neutral rating and slight downward revisions in their FFO and AFFO estimates.

Frequently Asked Questions

What is Citi's stance on Agree Realty Corporation?

Citi maintains a Neutral rating on Agree Realty Corporation with a price target set at $77.00.

What financial adjustments did Citi make?

Citi adjusted its financial model for Agree Realty, leading to minor reductions in FFO and AFFO estimates for 2024 and 2025.

What recent developments has Agree Realty announced?

Agree Realty has reported strong second-quarter financial results and expanded its revolving credit agreement, enhancing its financial flexibility.

How do analysts view Agree Realty’s performance?

While Stifel and RBC Capital Markets have raised their price targets, UBS has initiated Neutral coverage citing limited growth prospects.

What is Agree Realty's dividend history?

Agree Realty has paid dividends for 31 consecutive years and has a current yield of 3.99%, appealing to income-focused investors.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 5

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 6

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Portable Battery Charger Set to Transform EV Charging

Updated Category News Views 207

Introduction to the New Battery Charger for Electric Vehicles In a world where electric vehicles (EVs) are becoming more prevalent, the quest for convenience and reliability in charging options has led to the creation of an exciting new product. An inventive mind has developed a portable battery charger designed specifically for electric cars, addressing the significant...

Continue Reading
How to Calculate Rental Property Returns in Calgary

Updated Category Real Estate Views 549

The growth of the future value is not sufficient to invest in rental property, particularly in a market place such as Calgary where the economic cycles and population dynamics may affect the results. By computing the returns on the rental property, investors are able to know whether a property will be able to produce sustainable returns as they accumulate long te

Continue Reading
Understanding BioCardia's Upcoming Earnings Announcement

Updated Category News Views 196

BioCardia's Anticipated Earnings Report BioCardia (NASDAQ: BCDA) is gearing up for its next quarterly earnings announcement. Investors are keen to hear the results as they look to gain insights into the company's performance and future expectations. Expected Earnings Per Share Current estimates suggest that BioCardia will report an earnings per share (EPS) of...

Continue Reading
A New Look at Trump's First Month and Children's Concerns

Updated Category News Views 501

President Trump's Impact During His Initial Month As President Trump's new term unfolds, impactful events are shaping his administration's direction. The first month has been marked by significant developments, highlighted by the Senate's confirmation of Kash Patel as the Director of the FBI. This move is seen as a pivotal moment, emphasizing a commitment to addressing...

Continue Reading
Eramet Faces Revenue Decrease Amid Logistics Hurdles

Updated Category News Views 286

Eramet Revenue Decline in Q3 2025 Eramet has reported a decline in its adjusted turnover for the third quarter of 2025, which totaled €720 million. This marks a 10% decrease compared to the same quarter in 2024. The decrease primarily stems from significant external factors affecting sales and market conditions. Safety and CSR Achievements Despite facing a challenging...

Continue Reading